Efficacy of tulathromycin in the treatment of bovine respiratory disease associated with induced Mycoplasma bovis infections in young dairy calves |
| |
| Authors: | Godinho Kevin S Rae Al Windsor G David Tilt Nicola Rowan Tim G Sunderland Simon J |
| |
| Institution: | Veterinary Medicine Research and Development, Pfizer Ltd, Sandwich, Kent, UK. |
| |
| Abstract: | The efficacy of tulathromycin in the treatment of bovine respiratory disease (BRD) due to Mycoplasma bovis was determined following experimental infection. Two highly pathogenic strains of M. bovis (with minimum inhibitory concentration values for tulathromycin of 1 and >64 microg/ml) were inoculated into 145 calves. Four days after inoculation, calves with clinical BRD were treated subcutaneously with saline or tulathromycin (2.5 mg/kg). Compared with saline, BRD-related withdrawals, peak rectal temperatures, and lung lesion scores were significantly lower for tulathromycin-treated calves (P < .01). Tulathromycin was highly effective in the treatment of BRD due to M. bovis in calves regardless of the minimum inhibitory concentration of the challenge strain (1 or >64 microg/ml). |
| |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ |
|
